Episode Details

China's NMPA issued a notice on September 9, 2026, significantly streamlining the regulatory process for foreign manufacturers to localize the production of imported medical devices. This episode breaks down the key changes, including the ability to leverage original overseas registration materials for domestic submissions. We discuss which companies are affected, the requirements for demonstrating substantial equivalence, and the practical steps regulatory and quality teams should take to capitalize on this new, more efficient pathway to the Chinese market. Key Questions: - What is the new NMPA policy for localizing imported medical devices in China? - How does this change, effective September 9, 2026, affect foreign manufacturers? - Can overseas clinical and non-clinical data now be used for domestic registration? - What constitutes 'substantial equivalence' between an imported and a locally produced device? - Who is eligible to benefit from this streamlined pathway? - What are the immediate steps regulatory teams should take in response to this notice? - How does this policy reduce the time and cost of market access in China? - What documentation is required to prove the localized product is the same as the imported one? Sources: - https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH5_SGrB126Gd-NrbYAjDBPJwKs8J9NizRk5QxnblXLOAp59lcbPlZcTfa0t8G_FeByg5N5EXLrTCc6qSNt0-burNjqHFaCL8gqHH0Bf-Hdxc6I2w7GLcci_nfZPMwj1lqNxPE7cvgrAC_dDl_TUtI2z40ywDYhOBRpFp7hB9hNzh8zfNPA2o6UVKPAsb4oimdssGVc How Pure Global can help: Pure Global provides end-to-end regulatory consulting for MedTech and IVD companies. Our local experts in China and advanced AI tools can help your company navigate the NMPA's new localization policy, from assessing your existing dossiers to managing the submission process for domestic registration. We help you leverage this new pathway to accelerate your market presence in China. Contact us at info@pureglobal.com or visit https://pureglobal.com to learn more. Explore our free AI regulatory tools and device database at https://pureglobal.ai.